- Home
- CRVS vs LFCR Comparison
CRVS vs LFCR Comparison
Compare CRVS & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- LFCR
- Stock Information
- Founded
- CRVS 2014
- LFCR 1986
- Country
- CRVS United States
- LFCR United States
- Employees
- CRVS N/A
- LFCR N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- CRVS Health Care
- LFCR Health Care
- Exchange
- CRVS Nasdaq
- LFCR Nasdaq
- Market Cap
- CRVS 305.4M
- LFCR 308.8M
- IPO Year
- CRVS 2016
- LFCR N/A
- Fundamental
- Price
- CRVS $5.75
- LFCR $7.61
- Analyst Decision
- CRVS Strong Buy
- LFCR Buy
- Analyst Count
- CRVS 4
- LFCR 4
- Target Price
- CRVS $15.00
- LFCR $8.00
- AVG Volume (30 Days)
- CRVS 518.7K
- LFCR 108.3K
- Earning Date
- CRVS 08-07-2025
- LFCR 08-07-2025
- Dividend Yield
- CRVS N/A
- LFCR N/A
- EPS Growth
- CRVS N/A
- LFCR N/A
- EPS
- CRVS N/A
- LFCR N/A
- Revenue
- CRVS N/A
- LFCR $128,867,000.00
- Revenue This Year
- CRVS N/A
- LFCR $4.78
- Revenue Next Year
- CRVS N/A
- LFCR $12.02
- P/E Ratio
- CRVS N/A
- LFCR N/A
- Revenue Growth
- CRVS N/A
- LFCR 0.47
- 52 Week Low
- CRVS $2.54
- LFCR $3.68
- 52 Week High
- CRVS $10.00
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- LFCR 53.94
- Support Level
- CRVS $5.28
- LFCR $7.33
- Resistance Level
- CRVS $5.64
- LFCR $7.73
- Average True Range (ATR)
- CRVS 0.30
- LFCR 0.30
- MACD
- CRVS 0.03
- LFCR 0.03
- Stochastic Oscillator
- CRVS 77.70
- LFCR 65.33
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.